Candida Fratazzi

Inhaberin, President, BBCR, LLC

Cambridge, Vereinigte Staaten

Fähigkeiten und Kenntnisse

MD with more than 20 years of expertise in clinica
clinical plan
Drug Safety
Risk Managment
postmarketing
trial design
drug and device
regulatory knowledge US and EU
briefing documents
medical monitor
biomarkers
translational medicine
personalized medicine
genetic diseases
orphan indications
pediatrics and elderly studies.

Werdegang

Berufserfahrung von Candida Fratazzi

  • Bis heute

    President

    BBCR, LLC

Sprachen

  • Englisch

    -

  • Italienisch

    -

  • Spanisch

    -

Interessen

Innovative approach to drug and device development to address the growing trend of focusing on early stage strategies for effective and efficient trial designs in line with FDA and EMEA new rules.

XING Mitglieder mit ähnlichen Profilangaben

Gabriel Ricardo Morales Fallón

VP Emerging Markets at Pexin USA LLC Xplore

New York

Maria Weber

Lead Risk Management Physician

Rhein-Main

Janine Schneider

Central Pharmacovigilance Scientist

Nürnberg

Enzo Giglio

COO

Oftringen

Adam Reviczky

Vice President

London

Jurij Kiesner

MED Quality and Vigilance Consultant

Egerkingen

Hans-Jörg Kutschera

Vice President / Partner

München

Daniel DeLuca

President

Akron

Christoph Gibson

Vice President, Drug Discovery and Development

Berlin

Klaas Schneider

Vice President Technical Development

Geestland

Dr. Klaus Eisendle MBA

Director Academic Teaching Department of Dermatology, Venereology & Allergology

bolzano

Heinz Weidenthaler

Vice President Clinical Strategy, Infectious Diseases

Martinsried

Michael Fischer

drug safety specialist

Hannover

Jörg Dobers

Medical Writing Strategist Cardiovascular & Pulmonary Diseases (Director)

Berlin

Silvius Grobosch

VP Revenue Operations

Essen

Marcus Berger - GXP Expert

Stufenplanbeauftragter / Verantwortliche Person Pharmakovigilanz Schweiz

Köln und Bundesweit

Anne Brückner

Senior Safety Consultant Medical Review

München

Dr Sue Eugenia Humchack

President/ CEO

Phoenix

Elisabeth Willer

Global Program Regulatory Director

Holzkirchen

Friederike Wolfering

Global Pharmacovigilance Partner Manager

Ingelheim

21 Mio. XING Mitglieder, von A bis Z

Nachname:

ABCDEFGHIJKLMNOP
QRSTUVWXYZ